Phase II Trial to Assess the Activity of Ketoconazole Plus Lenalidomide in Patients With Prostate Cancer Progressive After Androgen Deprivation.
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Hydrocortisone (Primary) ; Ketoconazole (Primary) ; Lenalidomide (Primary) ; Aspirin
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- 19 Mar 2019 Status changed from active, no longer recruiting to completed.
- 06 Sep 2018 Primary endpoint (Number of Patients With a Partial Response, Progressive Disease, or Stable Disease Based on Prostate-Specific Antigen (PSA) or Measurable Disease) has not been met, as per the results published in the Investigational New Drugs
- 06 Sep 2018 Results published in the Investigational New Drugs